VK
Vivek Kumar Jain
About Vivek Kumar Jain
Data last updated:
Vivek Kumar Jain has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Akshardham Realinfra Private Limited and Shreeji Bio Science Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Akshardham Realinfra Private Limited at ₹1.49 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Apr 2022 | 2021 | ₹1.49 Cr (FY 2025) | Active | |
| Director | 27 Feb 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Kumar Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Kumar Jain
Vivek Kumar Jain has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Akshardham Realinfra Private Limited and Shreeji Bio Science Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Akshardham Realinfra Private Limited at ₹1.49 Cr (FY 2025).
Vivek Kumar Jain is associated with 2 companies as Director, including Akshardham Realinfra Private Limited (₹1.49 Cr), Shreeji Bio Science Private Limited.
Vivek Kumar Jain has expertise in General Business.
Vivek Kumar Jain has 4 years in corporate governance.
By reported revenue, the largest current company of Vivek Kumar Jain is Akshardham Realinfra Private Limited, with revenue of ₹1.49 Cr (FY 2025).
Vivek Kumar Jain currently holds positions at 2 companies: Akshardham Realinfra Private Limited (₹1.49 Cr), Shreeji Bio Science Private Limited.